Nimotuzumab and chemotherapy

DRUG3 trials

Sponsors

Peking University, Biotech Pharmaceutical Co., Ltd., Wei Guo

Conditions

Advanced Colorectal CancerHead and Neck Squamous Cell CarcinomaNon-small Cell Lung Cancer

Phase 1

Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer

WithdrawnNCT00985998

Biotech Pharmaceutical Co., Ltd.Non-small Cell Lung Cancer

Start: 2009-09-30End: 2015-08-31Updated: 2015-08-19

Phase 2

Study of Nimotuzumab to Treat Colorectal Cancer

Peking UniversityAdvanced Colorectal Cancer

Start: 2009-06-30End: 2010-04-30Target: 48Updated: 2009-09-07

Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma

CompletedNCT01425736

Wei GuoHead and Neck Squamous Cell Carcinoma

Start: 2009-01-31End: 2013-03-31Updated: 2014-06-03